Status:
RECRUITING
MucinB5 Gene Polymorphism and Leucocytes Telomere Length in Interstitial Lung Diseases
Lead Sponsor:
Sohag University
Conditions:
Mucin B5 rs (35705950) Gene Polymorphism in Interstitial Lung Diseases
Eligibility:
All Genders
18+ years
Brief Summary
This is an observertional study aimed at Study the association between Mucin B5 rs (35705950) gene polymorphism and Leucocytes telomere length in relation to interstitial lung diseases.
Eligibility Criteria
Inclusion
- This study will include patients with interstitial lung diseases aged above 18 years old.
Exclusion
- patients with emphysema or obstructive lung diseases.
- patients with active cancer
- End stage renal failure (GFR \< 30 ml/min) or on dialysis
- Liver cell failure
Key Trial Info
Start Date :
October 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06498141
Start Date
October 1 2023
End Date
December 31 2024
Last Update
July 12 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sohag university hosoital
Sohag, Egypt